AD |
Alzheimer’s disease |
Aβ |
Amyloid beta |
APP |
Amyloid precursor protein |
API |
Alzheimer’s Prevention Initiative |
APOE |
Apolipoprotein E |
APOE2 |
Apolipoprotein E, epsilon 2 allele |
APOE3 |
Apolipoprotein E, epsilon 3 allele |
APOE4 |
Apolipoprotein E, epsilon 4 allele |
ARIA |
Amyloid-related imaging abnormalities |
ARIA-E |
Amyloid-related imaging abnormalities vasogenic edema |
ARIA-H |
Amyloid-related imaging abnormalities cerebral microhemorrhages |
ARMS |
Amplification refractory mutation system |
ASO |
Antisense oligonucleotide |
AAV |
Adeno-associated virus |
BBB |
Blood-brain barrier |
CRISPR/Cas 9 |
Clustered regularly interspaced short palindromic repeats/associated protein 9 |
CNS |
Central nervous system |
CSF |
Cerebrospinal fluid |
FOPPR |
Fiber optic particle plasmon resonance |
GFAP |
Glial fibrillary acidic protein |
HSPG |
Heparan sulfate proteoglycans |
MCI |
Mild cognitive impairment |
MRI |
Magnetic resonance imaging |
NfL |
Neurofilament light chain |
NGS |
Next-generation sequencing |
PCR |
Polymerase chain reaction |
p-tau |
Phospho tau |
PET |
Positron emission tomography |
PSEN1 |
Presenilin 1 |
qPCR |
Quantitative polymerase chain reaction |
RFLP |
Restriction fragment length polymorphism |
SSP-PCR |
Sequence-specific primer polymerase chain reaction |